Literature DB >> 9310234

Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX.

L Wyld1, J L Burn, M W Reed, N J Brown.   

Abstract

Photodynamic therapy (PDT) may cause tumour cell destruction by direct toxicity or by inducing cellular hypoxia as a result of microcirculatory shutdown. Aminolaevulinic acid (ALA) causes cellular accumulation of protoporphyrin IX (PPIX) in cells exposed to it in excess. PPIX can be used as a photosensitizer for PDT. Microcirculatory shutdown may be induced by toxicity to the endothelial and vascular smooth muscle (VSM) cells or by release of vasoactive substances. We have studied whether PPIX is produced by endothelial, VSM and tumour cells on exposure to ALA and whether these cell lines are directly damaged by PDT in vitro. Tumour endothelial cells are angiogenic and we have, therefore, investigated the effect of cellular proliferation rates on PPIX generation. Tumour cells generate more PPIX intracellularly than the non-neoplastic cell lines studied and are correspondingly more sensitive to PDT-induced cytotoxicity. Endothelial cells are sensitive to PDT-induced cytotoxicity and accumulate between 1.5 and four times more PPIX when proliferating (as during tumour-induced angiogenesis) than when quiescent. We conclude that PPIX-mediated PDT may exert some of its effects on the microcirculation of treated tissues by direct toxicity to endothelial and VSM cells, and that this toxicity may be enhanced in the tumour microenvironment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310234      PMCID: PMC2228050          DOI: 10.1038/bjc.1997.450

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Effect of oxygen tension on haem and porphyrin biosynthesis.

Authors:  J E FALK; R J PORRA; A BROWN; F MOSS; H E LARMINIE
Journal:  Nature       Date:  1959-10-17       Impact factor: 49.962

2.  Photodynamic generation of hydroxyl radicals by hematoporphyrin derivative and light.

Authors:  J Van Steveninck; K Tijssen; J P Boegheim; J Van der Zee; T M Dubbelman
Journal:  Photochem Photobiol       Date:  1986-12       Impact factor: 3.421

3.  The microvascular effects of photodynamic therapy: evidence for a possible role of cyclooxygenase products.

Authors:  M W Reed; T J Wieman; K W Doak; C G Pietsch; D A Schuschke
Journal:  Photochem Photobiol       Date:  1989-09       Impact factor: 3.421

4.  An assessment of tumor cell viability after in vitro freezing.

Authors:  G Jacob; M N Kurzer; B J Fuller
Journal:  Cryobiology       Date:  1985-10       Impact factor: 2.487

5.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

6.  Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells.

Authors:  J B Mitchell; S McPherson; W DeGraff; J Gamson; A Zabell; A Russo
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

7.  A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation.

Authors:  M W Reed; T J Wieman; D A Schuschke; M T Tseng; F N Miller
Journal:  Radiat Res       Date:  1989-09       Impact factor: 2.841

8.  The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders.

Authors:  N Schoenfeld; O Epstein; M Lahav; R Mamet; M Shaklai; A Atsmon
Journal:  Cancer Lett       Date:  1988-12-01       Impact factor: 8.679

9.  Endothelial cell proliferation as a novel approach to targeting tumour therapy.

Authors:  J Denekamp
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

10.  The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.

Authors:  I J Stratford; M A Stephens
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-04       Impact factor: 7.038

View more
  20 in total

1.  Review of Neurosurgical Fluorescence Imaging Methodologies.

Authors:  Brian W Pogue; Summer Gibbs-Strauss; Pablo A Valdés; Kimberley Samkoe; David W Roberts; Keith D Paulsen
Journal:  IEEE J Sel Top Quantum Electron       Date:  2010-05       Impact factor: 4.544

2.  Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.

Authors:  Tetsuya Ogino; Hirotsugu Kobuchi; Kazuaki Munetomo; Hirofumi Fujita; Masanao Yamamoto; Toshihiko Utsumi; Keiji Inoue; Taro Shuin; Junzo Sasaki; Masayasu Inoue; Kozo Utsumi
Journal:  Mol Cell Biochem       Date:  2011-07-12       Impact factor: 3.396

3.  δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy.

Authors:  Pablo A Valdés; Anthony Kim; Marco Brantsch; Carolyn Niu; Ziev B Moses; Tor D Tosteson; Brian C Wilson; Keith D Paulsen; David W Roberts; Brent T Harris
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

4.  Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.

Authors:  C J Kelty; R Ackroyd; N J Brown; S B Brown; M W R Reed
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

5.  Photodynamic therapy with 5-aminolaevulinic acid and DNA damage: unravelling roles of p53 and ABCG2.

Authors:  I Postiglione; F Barra; S M Aloj; G Palumbo
Journal:  Cell Prolif       Date:  2016-07-07       Impact factor: 6.831

6.  Hypoxia significantly reduces aminolaevulinic acid-induced protoporphyrin IX synthesis in EMT6 cells.

Authors:  I Georgakoudi; P C Keng; T H Foster
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro.

Authors:  S L Gibson; J J Havens; M L Nguyen; R Hilf
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

8.  EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.

Authors:  Quan Zhou; Nynke S van den Berg; Eben L Rosenthal; Michael Iv; Michael Zhang; Johana C M Vega Leonel; Shannon Walters; Naoki Nishio; Monica Granucci; Roan Raymundo; Grace Yi; Hannes Vogel; Romain Cayrol; Yu-Jin Lee; Guolan Lu; Marisa Hom; Wenying Kang; Melanie Hayden Gephart; Larry Recht; Seema Nagpal; Reena Thomas; Chirag Patel; Gerald A Grant; Gordon Li
Journal:  Theranostics       Date:  2021-05-21       Impact factor: 11.556

9.  The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.

Authors:  L Wyld; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-05       Impact factor: 7.640

10.  Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.

Authors:  L Wyld; O Smith; J Lawry; M W Reed; N J Brown
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.